全文获取类型
收费全文 | 798篇 |
免费 | 65篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 29篇 |
妇产科学 | 7篇 |
基础医学 | 54篇 |
口腔科学 | 11篇 |
临床医学 | 75篇 |
内科学 | 216篇 |
皮肤病学 | 15篇 |
神经病学 | 24篇 |
特种医学 | 77篇 |
外科学 | 198篇 |
综合类 | 23篇 |
预防医学 | 68篇 |
眼科学 | 15篇 |
药学 | 17篇 |
中国医学 | 1篇 |
肿瘤学 | 37篇 |
出版年
2023年 | 8篇 |
2022年 | 12篇 |
2021年 | 13篇 |
2020年 | 15篇 |
2019年 | 16篇 |
2018年 | 18篇 |
2017年 | 16篇 |
2016年 | 14篇 |
2015年 | 16篇 |
2014年 | 28篇 |
2013年 | 23篇 |
2012年 | 28篇 |
2011年 | 26篇 |
2010年 | 21篇 |
2009年 | 38篇 |
2008年 | 35篇 |
2007年 | 30篇 |
2006年 | 19篇 |
2005年 | 36篇 |
2004年 | 32篇 |
2003年 | 34篇 |
2002年 | 30篇 |
2001年 | 22篇 |
2000年 | 16篇 |
1999年 | 24篇 |
1998年 | 18篇 |
1997年 | 15篇 |
1996年 | 19篇 |
1995年 | 12篇 |
1994年 | 14篇 |
1993年 | 23篇 |
1992年 | 17篇 |
1991年 | 10篇 |
1990年 | 12篇 |
1989年 | 10篇 |
1988年 | 22篇 |
1987年 | 22篇 |
1986年 | 16篇 |
1985年 | 21篇 |
1984年 | 5篇 |
1983年 | 4篇 |
1982年 | 8篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1973年 | 5篇 |
排序方式: 共有870条查询结果,搜索用时 0 毫秒
1.
2.
3.
青蒿琥酯皮肤擦剂在小鼠和兔体内的药代动力学研究 总被引:1,自引:0,他引:1
将青蒿琥酯溶于苯二甲酸二甲酯,加适量氨酮制成皮肤擦剂。给兔脱毛后,皮肤涂抹此擦剂25mg/kg后,血药浓度达峰时间平均为2 h,峰浓度平均为1.80μg/ml。药物在兔体内平均驻留时间为3.54 h,清除半衰期约为2.46 h。给小鼠脱毛皮肤涂抹擦剂6.7,31.3和71.4 mg/kg,血药浓度在给药后0.5~4 h达高峰,峰浓度分别为0.82,2.05和7.11μg/ml,体内药物平均驻留时间为3.39,2.79及3.54 h,清除半衰期为2.35,1.93及2.45 h。可见,给兔及小鼠皮肤擦剂后,青蒿琥酯吸收良好,血药浓度维持时间较长。 相似文献
4.
5.
Gilbert H. L. Tang Paul W. M. Fedak Terrence M. Yau Richard D. Weisel Alex Kulik Donald A. G. Mickle Ren-Ke Li 《European journal of cardio-thoracic surgery》2003,23(6):907-916
Current therapies for congestive heart failure are limited in efficacy or in applicability. Cardiac cell transplantation offers a novel therapeutic approach to improve heart function. Although significant progress has been made over the past decade in the development of cell transplantation, only recently have investigators studied the changes in ventricular function following cell transplantation. This review article describes the latest research developments, evaluates recent studies of ventricular function after cell transplantation, and discusses the future directions of cell transplantation as a new therapy to ‘repair broken hearts’. 相似文献
6.
7.
Rita C Marchi Michael H Meyer Norma B de Bosch C L Arocha-Pi?ango John W Weisel 《Blood coagulation & fibrinolysis》2004,15(7):559-567
An abnormal fibrinogen was identified in a 10-year-old male with a mild bleeding tendency; several years later, the patient developed a thrombotic event. Fibrin polymerization of plasma from the propositus and his mother, as measured by turbidity, was impaired. Plasmin digestion of fibrinogen and thrombin bound to the clot were both normal. The structure of clots from both plasma and purified fibrinogen was characterized by permeability, scanning electron microscopy and rheological measurements. Permeability of patients' clots was abnormal, although some measurements were not reliable because the clots were not mechanically stable. Consistent with these results, the stiffness of patients' clots was decreased approximately two-fold. Electron microscopy revealed that the patients' clots were very heterogeneous in structure. DNA sequencing of the propositus and his mother revealed a new unique point mutation that gives rise to a fibrinogen molecule with a missing amino acid residue at Aalpha-Asn 80. This new mutation, which would disrupt the alpha-helical coiled-coil structure, emphasizes the importance of this part of the molecule for fibrin polymerization and clot structure. This abnormal fibrinogen has been named fibrinogen Caracas VI. 相似文献
8.
9.
R D Weisel 《Canadian journal of surgery》1987,30(4):237-239
Coronary artery disease accounts for more than half of the morbidity and mortality associated with abdominal aortic surgery. To improve the results of vascular surgery, the risk of perioperative cardiac ischemia should be evaluated in each patient. Routine coronary angiography demonstrated severe correctable coronary artery disease in 14% of patients who had no history or electrocardiographic evidence of coronary artery disease. Exercise testing before abdominal aortic aneurysm repair will identify patients at high risk of cardiac ischemia. Dipyridamole-thallium imaging will identify high-risk patients before surgery for aortoiliac occlusive disease. Some patients with symptomatic coronary disease who are at extremely high risk should undergo preoperative coronary revascularization. Others should have their vascular surgery deferred, because their cardiac risk may exceed the anticipated benefit of the vascular surgery. Patients at moderate risk may need more intensive intraoperative monitoring. Patients without evidence of cardiac ischemia with stress may undergo vascular surgery with a low risk of perioperative cardiac ischemia. Finally, patients who have evidence of ischemic heart disease should be considered for coronary revascularization following successful vascular repair in order to prolong their survival. 相似文献
10.